Evidence map›Paper›PMID 39125780›Full record

ArticleInternational journal of molecular sciences2024

Bioenergetic and Inflammatory Alterations in Regressed and Non-Regressed Patients with Autism Spectrum Disorder.

Maria Gevezova, Zdravko Ivanov, Iliana Pacheva, Elena Timova, Maria Kazakova, Eleonora Kovacheva, Ivan Ivanov, Victoria Sarafian

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Maria GevezovaDepartment of Medical Biology, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria.
Zdravko IvanovDepartment of Medical Biology, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria.ORCID 0009-0004-2659-9696
Iliana PachevaDepartment of Pediatrics and Medical Genetics, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria.
Elena TimovaPediatrics Clinic, St. George University Hospital, 4002 Plovdiv, Bulgaria.
Maria KazakovaDepartment of Medical Biology, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria.
Eleonora KovachevaDepartment of Medical Biology, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria.
Ivan IvanovDepartment of Pediatrics and Medical Genetics, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria.
Victoria SarafianDepartment of Medical Biology, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria.ORCID 0000-0003-1501-0175

Funding

European Union-NextGenerationEU, through the National Recovery and Resilience Plan of the Republic of Bulgaria BG-RRP-2.004-0007-C01National Science Fund of Bulgaria KП-06-H33/6-2019
6 · The paper itself

Abstract

Autism spectrum disorder (ASD) is associated with multiple physiological abnormalities. Current laboratory and clinical evidence most commonly report mitochondrial dysfunction, oxidative stress, and immunological imbalance in almost every cell type of the body. The present work aims to evaluate oxygen consumption rate (OCR), extracellular acidification rate (ECAR), and inflammation-related molecules such as Cyclooxygenase-2 (COX-2), chitinase 3-like protein 1 (YKL-40), Interleukin-1 beta (IL-1β), Interleukin-9 (IL-9) in ASD children with and without regression compared to healthy controls. Children with ASD (n = 56) and typically developing children (TDC, n = 12) aged 1.11 to 11 years were studied. Mitochondrial activity was examined in peripheral blood mononuclear cells (PBMCs) isolated from children with ASD and from the control group, using a metabolic analyzer. Gene and protein levels of IL-1β, IL-9, COX-2, and YKL-40 were investigated in parallel. Our results showed that PBMCs of the ASD subgroup of regressed patients (ASD R(+), n = 21) had a specific pattern of mitochondrial activity with significantly increased maximal respiration, respiratory spare capacity, and proton leak compared to the non-regressed group (ASD R(-), n = 35) and TDC. Furthermore, we found an imbalance in the studied proinflammatory molecules and increased levels in ASD R(-) proving the involvement of inflammatory changes. The results of this study provide new evidence for specific bioenergetic profiles of immune cells and elevated inflammation-related molecules in ASD. For the first time, data on a unique metabolic profile in ASD R(+) and its comparison with a random group of children of similar age and sex are provided. Our data show that mitochondrial dysfunction is more significant in ASD R(+), while in ASD R(-) inflammation is more pronounced. Probably, in the group without regression, immune mechanisms (immune dysregulation, leading to inflammation) begin initially, and at a later stage mitochondrial activity is also affected under exogenous factors. On the other hand, in the regressed group, the initial damage is in the mitochondria, and perhaps at a later stage immune dysfunction is involved.

Indexed as

Autism Spectrum DisorderEnergy MetabolismInflammationLeukocytes, MononuclearMitochondriaChildChild, PreschoolChitinase-3-Like Protein 1Cyclooxygenase 2FemaleHumansInfantInterleukin-1betaMaleOxygen ConsumptionChitinase-3-Like Protein 1Cyclooxygenase 2Interleukin-1betaautismCOX-2cytokinesIL-1βIL-9metabolismYKL-40

Identifiers

PMID39125780
PMCPMC11311370

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.